High-dose Inhaled NO Therapy for the pREvenvention of NP After Cardiac Surgery Under CPB

NCT06261827 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Nosocomial Pneumonia

Interventions

DRUG: Sham treatment
DRUG: 200-ppm NO

Sponsor

Tomsk National Research Medical Center of the Russian Academy of Sciences